Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with demonstrated activity against multidrug-resistant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Skripconoka, Vija, Danilovits, Manfred, Pehme, Lea, Tomson, Tarmo, Skenders, Girts, Kummik, Tiina, Cirule, Andra, Leimane, Vaira, Kurve, Anu, Levina, Klavdia, Geiter, Lawrence J., Manissero, Davide, Wells, Charles D.
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669462/
https://ncbi.nlm.nih.gov/pubmed/23018916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00125812
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados